Thursday, September 23, 2010 9:40:18 AM
I would be VERY careful listening to ANYTHING Zacks says. Look right above at post number 3705. That was in October of 2009 and Zacks rated this company as an OUTPERFORM. On October 26 of 2009, when Zacks made this silly prediction, OXBT was sitting at just under $8.00 a share. This morning OXBT is right around $2.50 a share. That is a loss of right around 68%. Yes, I would be VERY careful taking ANYTHING Zacks says as being valid. You might also want to research just why Zacks decided to conduct a review of OXBT.
Recent TENX News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/22/2026 12:21:35 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 12:19:57 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 12:17:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2026 12:00:16 PM
- Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer • GlobeNewswire Inc. • 04/22/2026 11:00:00 AM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/08/2026 10:26:03 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/24/2026 03:41:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/10/2026 11:48:55 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 11:32:44 AM
- Tenax Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 03/10/2026 11:00:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/09/2026 04:24:22 PM
- Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference • GlobeNewswire Inc. • 03/03/2026 12:00:00 PM
- Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 • GlobeNewswire Inc. • 02/04/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/14/2026 02:49:18 AM

